Interleukin-15 (IL-15) Manufacturing Indonesia

• 

  The Role of Biotechnology in Interleukin-15 (IL-15) Manufacturing

  Although there has been a vast improvement in Yaohai  Interleukin-15 (IL-15) Manufacturing, it is still not easy for the researchers to address every challenge upfront. A major obstacle is the safety of  Yaohai Interleukin-15 (IL-15) in humans. These, in turn must be extensively tested so they don't produce bad side effects. Treatments must always be fully safe.

• 

  Challenges and Opportunities in Interleukin-15 (IL-15) Manufacturing

  The second challenge researchers face has to do with the expense of producing  Yaohai Interleukin-15 (IL-15). The difficulty is when you are trying to do it in the lab, which is expensive and so would make less people able to be treated. So, while scientists are struggling to make Yaohai  Interleukin-15 (IL-15) more accessible or cheaper. Being a concentrated industry, they want to make this perhaps life-saving treatment more available for a larger group of people.

• 

  From Concept to Commercialization.

   Yaohai Interleukin-15 (IL-15) was identified about two decades ago but it takes a lot of time to reach at this point to produce  Yaohai Interleukin sirkRNA-15 (IL-15) for treatment of various diseases. It will be some years before Yaohai  Interleukin mRNA-15 (IL-15) therapy can be considered safe to treat humans. The process is one where many hands help science be sure it is right.

Why choose Yaohai Interleukin-15 (IL-15) Manufacturing?

• Keahlian Profesional & Pengalaman Luas

  Yaohai Bio-Pharma is a leading in Interleukin-15 (IL-15) Manufacturing CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.

• Rantai Pasokan & Kemampuan Manufaktur yang Kuat

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have established an advanced facility that is equipped with modern facilities and strong RD manufacturing capabilities. We have five drug substance manufacturing lines that are in compliance with GMP requirements for microbial fermentation and purification, as well as two fill-finish lines that are automated for cartridges, vials, as well as pre-filled syringes. The available fermentation scales vary from 100L to 500L, 1000L and 2000L. Interleukin-15 (IL-15) Manufacturing for vias are 1ml to 25ml, whereas the pre-filled syringes and cartridge filling specifications cover 1-3ml. Our production workshop is cGMP compliant and guarantees steady supply of clinical samples as well as commercial items. Our plant produces large molecules which are shipped to the globe.

• Sistem Mutu & Kepatuhan Terhadap Peraturan Global

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and Interleukin-15 (IL-15) Manufacturing. We have developed a solid quality system that adheres to current GMP standards and regulatory requirements worldwide. Our regulatory team is knowledgeable on global regulatory frameworks to expedite biological launches. We make sure that production processes are traceable with high-quality products as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also in compliance. Yaohai BioPharma successfully passed an on-site audit conducted by a Qualified Person from the European Union (QP) to examine our GMP process and manufacturing facility. We also successfully been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Kustomisasi, Efisiensi & Efektivitas Biaya

  Yaohai Bio-Pharma has experience in the manufacture of biologics created from microorganisms We offer bespoke RD solutions as well as manufacturing services while minimizing the risk We've worked with diverse modalities such as recombinant subunit vaccines peptides hormones cytokines growth factors mono-domain antibodies enzymes plasmid DNA the mRNA and other We've specialized in several microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) bacteria intracellular soluble and inclusion bodies (yields up to 10g/L) We have also created a BSL-2 fermentation system to create Interleukin-15 (IL-15) Manufacturing vaccines We are experts in optimizing production processes increasing yields and decreasing costs We have a highly efficient technology team that ensures timely and top-quality project delivery This allows us to deliver your products that are unique faster to the market

Kategori produk terkait

• Produksi Biosimilar Elapegademase
• Produksi Biosimilar Glukarpidase
• Pengembangan dan Pembuatan Biosimilar Mikroba
• RNA Lyophilization Protocol
• Studi Stabilitas Biologi
• Proses Pelarutan Badan Inklusi
• IND and BLA Filling Checklist
• Large-Molecules Fill and Finish
• Pengisian dan Penyelesaian Steril
• Produksi Biosimilar PTH 1-34

Tidak menemukan apa yang Anda cari?
Hubungi konsultan kami untuk lebih banyak produk yang tersedia.